| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V96736 | (R)-Crinecerfont | 2649012-21-3 | (R)-Crinecerfont is the R isomer of Crinecerfont. |
|
V97850 | CFTR corrector 15 | 1170387-92-4 | CFTR Corrector 15 (Compound 4172) is a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) that, when combined with VX-809, can repair the F508del-CFTR folding defect. |
|
V97466 | CFTR corrector 16 | 1210305-23-9 | CFTR calibrator 16 (Compound 39) is a calibrator of the cystic fibrosis transmembrane conductance regulator (CFTR) and can be used in the study of cystic fibrosis. |
|
V87136 | IDOR-4 | 2839901-24-3 | IDOR-4 is a type IV CFTR corrector. |
|
V106262 | kCAL01 | 1364717-03-2 | kCAL01 is a CAL inhibitor with a Ki value of 2.3 μM. |
|
V2875 | PPQ-102 | 931706-15-9 | PPQ-102 (also known as CFTR Inhibitor) is a potentinhibitor of CFTR (cystic fibrosis transmembrane conductance regulator) discovered from screening of approximately 110000 small synthetic and natural compounds for inhibition of halide influx in CFTR-expressing epithelial cells. |
|
V3314 | PTI-428 | 1953130-87-4 | PTI-428 is a novel, potent CFTR amplifier being developed byProteostasis Therapeutics, Inc. |
|
V147045 | VU439 | VU439 is a functionalized photoaffinity ligand for Elexacaftor. | |
|
V3551 | FDL-169 | 1628416-28-3 | FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) correctorbeing developed by Flatley Discovery Lab for treating cystic fibrosis (CF) patients who carry the F508del mutation, the most common mutation in this disease. |